SPIEGELMAN DANIEL K — SEC Form 4 filings
SEC reporting owner CIK 1238403. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-05-24 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 7,576 shares, $167,013 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 3,788 shares @ $22.05 ($83,525) in MYRIAD GENETICS INC, filed 2024-06-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | Director | 2 | — | 2 legs · 7,576 sh · $167,013 | — |
| SPRUCE BIOSCIENCES, INC. (SPRB) | Director | 4 | — | — | 9 |
| vTv Therapeutics Inc. (VTVT) | Director | 3 | — | — | 3 |
| Kyverna Therapeutics, Inc. (KYTX) | Director | 1 | — | — | 2 |
| Maze Therapeutics, Inc. (MAZE) | Director | 2 | — | — | 2 |
Form 4 filings — SPIEGELMAN DANIEL K
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | vTv Therapeutics Inc. (VTVT) | Grant/award (A): 6,000 (derivative) @ $35.08 | EDGAR |
| 2026-06-10 | 4 | Maze Therapeutics, Inc. (MAZE) | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | SPRUCE BIOSCIENCES, INC. (SPRB) | Grant/award (A): 1,700 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | SPRUCE BIOSCIENCES, INC. (SPRB) | Grant/award (A): 458 (derivative) · Disposition to issuer (D): 458 (derivative) · Grant/award (A): 88 (derivative) · Disposition to issuer (D): 88 (derivative) · Grant/award (A): 400 (derivative) · Disposition to issuer (D): 400 (derivative) | EDGAR |
| 2025-09-24 | 4 | Maze Therapeutics, Inc. (MAZE) | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2025-07-24 | 4 | SPRUCE BIOSCIENCES, INC. (SPRB) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | vTv Therapeutics Inc. (VTVT) | Grant/award (A): 4,000 (derivative) @ $16.59 | EDGAR |
| 2025-06-02 | 4 | Kyverna Therapeutics, Inc. (KYTX) | Grant/award (A): 16,634 @ $0 · Grant/award (A): 65,351 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | vTv Therapeutics Inc. (VTVT) | Grant/award (A): 6,000 (derivative) @ $17.22 | EDGAR |
| 2024-06-07 | 4 | MYRIAD GENETICS INC (MYGN) | Holdings only — no transactions reported | EDGAR |
| 2024-06-04 | 4 | MYRIAD GENETICS INC (MYGN) | Sale (S): 3,788 @ $22.04 · Sale (S): 3,788 @ $22.05 | EDGAR |
| 2024-05-24 | 4 | SPRUCE BIOSCIENCES, INC. (SPRB) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1238403 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →